Findings: Implementation of the C-SSRS by nonpsychiatric subspecialty staff members was feasible and valid. Interviewers' conclusions based on this instrument matched those of the mental health professional who followed up with participants. Process notes contained themes about the participants, including anger and sadness in survivors and the physical and emotional demands of the survivor in caregivers. Progress notes for the interviewer included a reiteration of events, whether the assessment was successful, and whether the recommendation of the interviewer was in agreement with that of the mental health professional.
Conclusions:
The protocol based on the C-SSRS was useful and feasible for nonpsychiatric subspecialty staff members to use in the collection of data from survivors of childhood brain tumors and their caregivers. Several submissions to the U.S. Food and Drug Administration (FDA) demonstrated significant variation in the methods used to report suicidal thoughts and behaviors during traditional interviews by clinicians supervising antidepressant clinical trials. These findings challenge the validity of the clinical interview as the gold standard for the assessment of suicidal ideation in the clinical trial setting. The presence of variations in reporting methods supported the need to improve the evaluation of suicidal thoughts to detect small fluctuations that may be related to treatment efforts (Posner et al., 2011; Zimmerman, Chelminski, & Posternak, 2004 , 2005 . Suicidal ideation was reported in clinical trials of pharmaceuticals that were not being tested for the treatment of psychiatric disorders. To prevent this untoward event, effective assessment was merited (FDA, 2012) .
The specific assessment of suicidal ideation and behavior during the course of research was not required 
